Measurement of the glycaemic index (GI) of two enteral nutrition formulations in healthy subjects

Measurement of the glycaemic index (GI) of two enteral nutrition formulations in healthy subjects - GCOT-001-CEN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00006185

Enrollment

Registered

2014-05-30

Start date

2014-06-03

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

Group 1: HV 1127, single oral intake of a volume corresponding to 50 g available carbohydrates Group 2: Glucerna 1.5, single oral intake of a volume corresponding to 50 g available carbohydrates Group

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy subjects who give informed consent to participate in the study

Exclusion criteria

Exclusion criteria: - Aged 60 years - Pregnant or lactating - Body mass index (BMI) 30kg/m2 or above - History of diabetes mellitus or fasting blood glucose value >6.1mmol/L - Any known food allergy or intolerance - Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or influence digestion and absorption of nutrients - Use of steroids, protease inhibitors, amphetamines or antipsychotics - Use of medications known to affect glucose tolerance (excluding oral contraceptives)

Design outcomes

Primary

Measure	Time frame
Determination of the glycaemic index (GI)	—

Countries

United Kingdom

Contacts

Public ContactSteffen Benzing

Fresenius Kabi Deutschland GmbH

steffen.benzing@fresenius-kabi.com06172-686-7709

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026